http://www.xconomy.com/seattle/2009/04/28/no-devil-in-details-dendreon-data-stands-up-to-scrutiny-from-doctors-investors/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 09:14:03 +0000 hourly 1 http://wordpress.org/?v=3.0.4 http://www.xconomy.com/seattle/2009/04/28/no-devil-in-details-dendreon-data-stands-up-to-scrutiny-from-doctors-investors/comment-page-1/#comment-281990 The Medical Quack: Dendreon Announces Expanding to Europe to Seek Approval and Potential Factory in Germany Tue, 11 Jan 2011 05:18:31 +0000 http://www.xconomy.com/?p=22169#comment-281990 [...] or in early 2012. Based on preliminary talks with regulators there, the company said it expects the same 512-patient trial that clinched Provenge’s approval in the U.S. ought to be good enough to seek approval in the [...] [...] or in early 2012. Based on preliminary talks with regulators there, the company said it expects the same 512-patient trial that clinched Provenge’s approval in the U.S. ought to be good enough to seek approval in the [...]

]]>